Medtronic stock ends the day slightly lower at the close on the NYSE

Medtronic stock closed modestly lower on the NYSE on September 21, 2026, slipping a small fraction of a percent versus its prior close in U.S. dollars. The move left the shares broadly in line with a flat-to-slightly weaker performance across major U.S. benchmarks for the day.

September 21, 2026 in numbers

Medtronic plc (ISIN IE00BTN1Y115, NYSE: MDT) ended the regular session on September 21, 2026 at a U.S.-listed closing price that was fractionally below the prior day’s level, with the stock’s daily percentage change remaining within a narrow band typical of a quiet trading day. Intraday, the U.S.-listed shares oscillated within a relatively tight range between their opening print and the day’s high and low, and the closing price stayed comfortably inside that intraday span. Per exchange data, overall trading volume for the session was broadly consistent with the average daily volume reported for Medtronic’s U.S. listing, indicating no marked surge or drought in liquidity compared with recent weeks. Compared with a major U.S. large-cap benchmark such as the S&P 500, which finished close to unchanged on the day, Medtronic’s modest decline left it only slightly weaker than the broader market.

In the issuer’s European home market, Medtronic’s shares had already completed their local-session trading earlier on September 21, 2026, with the home-market percentage move recorded at the time of that close in Eastern Time falling in a similar low-single-digit band as the U.S. performance; the difference between the two venues’ percentage moves primarily reflected the prevailing exchange rate between euros and U.S. dollars rather than a distinct shift in investor sentiment. The U.S.-listed shares also remained comfortably within their 52-week trading range in U.S. dollars, with the September 21, 2026 close sitting noticeably below the 52-week high but still well above the 52-week low, underscoring that the day’s modest decline did not materially alter the longer-term price picture.

After the bell and next catalysts

After the closing bell on September 21, 2026, Medtronic’s U.S.-listed shares continued to trade in the extended session on their U.S. venue, with after-hours prices remaining close to the official regular-session close and no pronounced deviation reported during the early part of the evening. Investors are now looking ahead to the next U.S. trading day, September 22, 2026, when broader healthcare-sector developments and scheduled economic releases could influence sentiment toward large medical-technology names such as Medtronic. Upcoming industry conferences and potential regulatory or reimbursement updates over the following trading days also have the capacity to affect the stock’s trajectory, particularly if peers in the medical devices space provide fresh guidance or if macroeconomic data shift expectations for interest rates and hospital capital spending.